Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389557053402800PMID 15638788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolomics – the link between genotypes and phenotypes

  2004cited by this paper
• Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis

  2003cited by this paper
• 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS)

  2002cited by this paper
• Metabolic control analysis in drug discovery and disease

  2002cited by this paper
• Metabolic profiling of cell growth and death in cancer: applications in drug discovery.

  2002cited by this paper
• Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays

  2002cited by this paper
• Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone.

  2002cited by this paper
• Application of metabolomics to plant genotype discrimination using statistics and machine learning

  2002cited by this paper
• Metabonomics: a platform for studying drug toxicity and gene function

  2002cited by this paper
• Sample preparation in matrix-assisted laser desorption/ionization mass spectrometry of whole bacterial cells and the detection of high mass (>20 kDa) proteins.

  2002cited by this paper
• Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.

  2002cited by this paper
• Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening*

  2001cited by this paper
• Use of Direct-Infusion Electrospray Mass Spectrometry To Guide Empirical Development of Improved Conditions for Expression of Secondary Metabolites from Actinomycetes

  2001cited by this paper
• Discrimination of aerobic endospore-forming bacteria via electrospray-lonization mass spectrometry of whole cell suspensions.

  2001cited by this paper
• A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations

  2001cited by this paper
• Rapid Method To Estimate the Presence of Secondary Metabolites in Microbial Extracts

  2001cited by this paper
• Visualizing plant metabolomic correlation networks using clique-metabolite matrices

  2001cited by this paper
• Combining Genomics, Metabolome Analysis, and Biochemical Modelling to Understand Metabolic Networks

  2001cited by this paper
• Genomic computing. Explanatory analysis of plant expression profiling data using machine learning.

  2001cited by this paper
• Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway

  2001cited by this paper
• Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin.

  2001cited by this paper
• An NMR‐based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse

  2000cited by this paper
• Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins.

  2000cited by this paper
• Metabolite profiling for plant functional genomics

  2000cited by this paper
• Small-molecule inhibitors of the cell cycle.

  2000cited by this paper
• Frontiers in chemical genetics.

  2000cited by this paper
• Target-oriented and diversity-oriented organic synthesis in drug discovery.

  2000cited by this paper
• Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis.

  2000cited by this paper
• Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.

  2000cited by this paper
• Small molecule developmental screens reveal the logic and timing of vertebrate development.

  2000cited by this paper
• Chemical genetics: exploring and controlling cellular processes with chemical probes.

  1999cited by this paper
• 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.

  1999cited by this paper
• Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins.

  1999cited by this paper
• Correlation between Protein and mRNA Abundance in Yeast

  1999cited by this paper
• Systematic functional analysis of the yeast genome.

  1998cited by this paper
• Structure of human methionine aminopeptidase-2 complexed with fumagillin.

  1998cited by this paper
• Rapid identification of urinary tract infection bacteria using hyperspectral whole-organism fingerprinting and artificial neural networks.

  1998cited by this paper
• The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.

  1997cited by this paper
• Deciphering isozyme function: exploring cell biology with chemistry in the post-genomic era.

  1996cited by this paper
• The Regulation of Cellular Systems

  1996cited by this paper
• Understanding and controlling the cell cycle with natural products.

  1996cited by this paper
• Understanding the Control of Metabolism

  1996cited by this paper
• FK506 and cyclosporin, molecular probes for studying intracellular signal transduction.

  1993cited by this paper
• Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.

  1993cited by this paper
• Immunophilin-sensitive protein phosphatase action in cell signaling pathways.

  1992cited by this paper
• Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent.

  1992cited by this paper
• Chemistry and biology of the immunophilins and their immunosuppressive ligands.

  1991cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper

• Assessment of oat varieties with different levels of breeding refinement from the Vavilov Institute’s collection applying the method of metabolomic profiling

  2022cites this paper
• Metabolomics approach in digital assessment of fatty acids profile of cottonseed for biological activity improvement of cotton oil

  2020cites this paper
• Application of Metabolomic Analysis in Exploration of Plant Genetic Resources

  2019cites this paper
• NMR and MS-based Stable Isotope-Resolved Metabolomics and Applications in Cancer Metabolism.

  2019cites this paper
• Study of levan productivity from Bacillus subtilis Natto by surface response methodology and its antitumor activity against HepG2 cells using metabolomic approach.

  2015cites this paper
• THE EFFECTS OF METFORMIN ON PANCREATIC CANCER METABOLISM

  2014cites this paper
• Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS.

  2014cites this paper
• Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease.

  2014cites this paper
• Effects of dietary glucose supplementation on the fasted plasma metabolome in cats and dogs

  2013cites this paper
• Natural Product-Based Drug Discovery in Africa: The Need for Integration into Modern Drug Discovery Paradigms

  2012cites this paper
• Clinical Aspects of Metabolomics

  2012cites this paper
• Introduction to Metabolomics

  2012cites this paper
• Modulating testosterone pathway: a new strategy to tackle male skin aging?

  2012cites this paper
• Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs

  2012influential citation
• ADAP-GC 2.0: deconvolution of coeluting metabolites from GC/TOF-MS data for metabolomics studies.

  2012cites this paper
• 8 Metabolic Pathways as Targets for Drug Screening

  2012cites this paper
• A systems biology approach to nutritional immunology - focus on innate immunity.

  2012cites this paper
• Metabolic Pathways as Targets for Drug Screening

  2012cites this paper
• Stable isotope-resolved metabolomics and applications for drug development.

  2012cites this paper
• How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?

  2011cites this paper
• Characterization of low molecular weight chemical fractions of dry bean (Phaseolus vulgaris) for bioactivity using Caenorhabditis elegans longevity and metabolite fingerprinting.

  2010cites this paper
• Application of Fourier-transform ion cyclotron resonance mass spectrometry to metabolic profiling and metabolite identification.

  2010cites this paper
• A metabolomics study of selected perturbations of normal human metabolism

  2010cites this paper
• Fast targeted multidimensional NMR metabolomics of colorectal cancer

  2009cites this paper
• Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research

  2009cites this paper
• Isotopomer-based metabolomic analysis by NMR and mass spectrometry.

  2008cites this paper
• Biomarker Discovery in Diabetic Nephropathy by Targeted Metabolomics

  2008cites this paper
• Metabolic Markers of Hypoxia: Systems Biology Application in Biomedicine

  2008cites this paper
• Reverse Pharmacognosy: Identifying Biological Properties for Plants by Means of their Molecule Constituents: Application to Meranzin

  2007cites this paper
• Large compound databases for structure-activity relationships studies in drug discovery.

  2007cites this paper
• Metabonomics in pharmaceutical discovery and development.

  2007cites this paper
• Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxes.

  2007cites this paper
• Reverse pharmacognosy: identifying biological properties for plants by means of their molecule constituents: application to meranzin.

  2007cites this paper
• Chapter 9 – Metabonomics in Preclinical Pharmaceutical Discovery and Development

  2007cites this paper
• Chemical intervention in signalling networks: recent advances and applications†

  2006cites this paper
• Networkcentric healthcare and bioinformatics: Unified operations within three domains of knowledge

  2006cites this paper
• PNU-91325 increases fatty acid synthesis from glucose and mitochondrial long chain fatty acid degradation: a comparative tracer-based metabolomics study with rosiglitazone and pioglitazone in HepG2 cells

  2006cites this paper
• Characterizing phenotype with tracer based metabolomics

  2006influential citation
• Novel approaches for characterizing the riboflavin transport and trafficking mechanism and its potential as a target in breast cancer.

  2005cites this paper
• Nutrient-gene interaction: tracer-based metabolomics.

  2005cites this paper